Baxter lowers FY25 adjusted EPS view to $2.35-$2.40 from $2.42-$2.53

Consensus $2.44. The company said, “Baxter (BAX) now expects sales growth from continuing operations of 4% to 5% on a reported basis. On an operational basis, Baxter now expects sales growth of 1% to 2%. The company now expects adjusted earnings from continuing operations, before special items, of $2.35 to $2.40 per diluted share.”